Received May 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | UK118AA | SC / RA |
| TYP | TYPHOID VI POLYSACCHARIDE (TYPHIM VI) | SANOFI PASTEUR | 1 | Y2A021M | IM / LA |
Patient developed severe shooting pain in the right arm after vaccination with the yellow fever vaccine. She was seen by physical therapy the day after her travel clinic appointment. No fevers, redness, warmth. Patient reported having been vaccinated with YF vaccination 60 years prior but had no documentation.
None
Diabetes type 2, hypertension
alendronate, amlodipine, vitamin C, citracal +D, conjugated estrogen vaginal cream, ferrous sulfate, hydrochlorothiazide, probiotic-10, losartan, metformin, multivitamin, pantoprazole, (research study atorvastatin or placebo)
NKA
Evaluated by physical therapy on 8 May 2025 (day after vaccination).